Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease
Clinical trial NCT01282762 · COMPLETED
Trial details
- NCT number
- NCT01282762
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-08-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.